CN115462429A - Multifunctional health tea composition - Google Patents
Multifunctional health tea composition Download PDFInfo
- Publication number
- CN115462429A CN115462429A CN202211123122.0A CN202211123122A CN115462429A CN 115462429 A CN115462429 A CN 115462429A CN 202211123122 A CN202211123122 A CN 202211123122A CN 115462429 A CN115462429 A CN 115462429A
- Authority
- CN
- China
- Prior art keywords
- parts
- improving
- cistanche
- multifunctional health
- liquorice
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 20
- 230000036541 health Effects 0.000 title claims abstract description 17
- 241001122767 Theaceae Species 0.000 title 1
- 244000269722 Thea sinensis Species 0.000 claims abstract description 26
- 240000005373 Panax quinquefolius Species 0.000 claims abstract description 13
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 13
- 241001076416 Dendrobium tosaense Species 0.000 claims abstract description 12
- 240000005739 Eurycoma longifolia Species 0.000 claims abstract description 12
- 241000005787 Cistanche Species 0.000 claims abstract description 11
- 244000303040 Glycyrrhiza glabra Species 0.000 claims abstract description 10
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 10
- 241000096284 Gynochthodes officinalis Species 0.000 claims abstract description 10
- 244000197580 Poria cocos Species 0.000 claims abstract description 10
- 235000008599 Poria cocos Nutrition 0.000 claims abstract description 10
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims abstract description 10
- 235000011477 liquorice Nutrition 0.000 claims abstract description 10
- 235000017784 Mespilus germanica Nutrition 0.000 claims abstract description 9
- 244000182216 Mimusops elengi Species 0.000 claims abstract description 9
- 235000000560 Mimusops elengi Nutrition 0.000 claims abstract description 9
- 235000007837 Vangueria infausta Nutrition 0.000 claims abstract description 9
- 235000007516 Chrysanthemum Nutrition 0.000 claims description 4
- 244000189548 Chrysanthemum x morifolium Species 0.000 claims description 4
- 240000002948 Ophiopogon intermedius Species 0.000 claims 1
- 235000001188 Peltandra virginica Nutrition 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 10
- 210000004369 blood Anatomy 0.000 abstract description 6
- 239000008280 blood Substances 0.000 abstract description 6
- 239000003814 drug Substances 0.000 abstract description 6
- 230000036039 immunity Effects 0.000 abstract description 5
- 208000025865 Ulcer Diseases 0.000 abstract description 3
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 abstract description 3
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 abstract description 3
- 230000002708 enhancing effect Effects 0.000 abstract description 3
- 230000003907 kidney function Effects 0.000 abstract description 3
- 206010029446 nocturia Diseases 0.000 abstract description 3
- 231100000397 ulcer Toxicity 0.000 abstract description 3
- 229940116269 uric acid Drugs 0.000 abstract description 3
- 238000001784 detoxification Methods 0.000 abstract description 2
- 230000001105 regulatory effect Effects 0.000 abstract description 2
- 235000013616 tea Nutrition 0.000 description 21
- 230000000052 comparative effect Effects 0.000 description 9
- 230000006870 function Effects 0.000 description 6
- 206010028980 Neoplasm Diseases 0.000 description 5
- 230000001737 promoting effect Effects 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 3
- 206010012601 diabetes mellitus Diseases 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 244000128583 Coreopsis cardaminifolia Species 0.000 description 2
- 235000005912 Coreopsis cardaminifolia Nutrition 0.000 description 2
- 108010006464 Hemolysin Proteins Proteins 0.000 description 2
- 102000019197 Superoxide Dismutase Human genes 0.000 description 2
- 108010012715 Superoxide dismutase Proteins 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 239000003228 hemolysin Substances 0.000 description 2
- 210000002540 macrophage Anatomy 0.000 description 2
- 230000002107 myocardial effect Effects 0.000 description 2
- 230000000242 pagocytic effect Effects 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 210000001541 thymus gland Anatomy 0.000 description 2
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 206010002660 Anoxia Diseases 0.000 description 1
- 241000976983 Anoxia Species 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 241000336315 Cistanche salsa Species 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 208000006313 Delayed Hypersensitivity Diseases 0.000 description 1
- 206010013789 Dry throat Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 241001180747 Hottea Species 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 244000241838 Lycium barbarum Species 0.000 description 1
- 235000015459 Lycium barbarum Nutrition 0.000 description 1
- 235000015468 Lycium chinense Nutrition 0.000 description 1
- 206010057672 Male sexual dysfunction Diseases 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- ZSJLQEPLLKMAKR-UHFFFAOYSA-N Streptozotocin Natural products O=NN(C)C(=O)NC1C(O)OC(CO)C(O)C1O ZSJLQEPLLKMAKR-UHFFFAOYSA-N 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 241000255588 Tephritidae Species 0.000 description 1
- 235000006468 Thea sinensis Nutrition 0.000 description 1
- 208000005946 Xerostomia Diseases 0.000 description 1
- 208000031975 Yang Deficiency Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000003470 adrenal cortex hormone Substances 0.000 description 1
- 210000004100 adrenal gland Anatomy 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 230000007953 anoxia Effects 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 235000020279 black tea Nutrition 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 230000001143 conditioned effect Effects 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- RKHQGWMMUURILY-UHRZLXHJSA-N cortivazol Chemical compound C([C@H]1[C@@H]2C[C@H]([C@]([C@@]2(C)C[C@H](O)[C@@H]1[C@@]1(C)C2)(O)C(=O)COC(C)=O)C)=C(C)C1=CC1=C2C=NN1C1=CC=CC=C1 RKHQGWMMUURILY-UHRZLXHJSA-N 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000000762 glandular Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000009569 green tea Nutrition 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 210000003563 lymphoid tissue Anatomy 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000000822 natural killer cell Anatomy 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 230000003860 sleep quality Effects 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- ZSJLQEPLLKMAKR-GKHCUFPYSA-N streptozocin Chemical compound O=NN(C)C(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O ZSJLQEPLLKMAKR-GKHCUFPYSA-N 0.000 description 1
- 229960001052 streptozocin Drugs 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 230000004218 vascular function Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/34—Tea substitutes, e.g. matè; Extracts or infusions thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/64—Orobanchaceae (Broom-rape family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
- A61K36/725—Ziziphus, e.g. jujube
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/746—Morinda
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8968—Ophiopogon (Lilyturf)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
- A61K36/8984—Dendrobium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Immunology (AREA)
- Toxicology (AREA)
- Urology & Nephrology (AREA)
- Emergency Medicine (AREA)
- Food Science & Technology (AREA)
- Rheumatology (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pain & Pain Management (AREA)
- Physical Education & Sports Medicine (AREA)
- Polymers & Plastics (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
Abstract
The invention relates to the technical field of health preserving videos, and particularly relates to a multifunctional health preserving tea composition which comprises the following components in parts by weight: 2-4 parts of cistanche, 1-3 parts of eurycoma longifolia, 1-3 parts of dendrobium officinale, 1-3 parts of American ginseng, 0.5-2 parts of radix ophiopogonis, 1-2 parts of morinda officinalis, 3-6 parts of poria cocos, 2-5 parts of medlar, 0.5-2 parts of liquorice, 2-4 parts of spina date seeds and 1-3 parts of dried orange peel. The composition obtained by reasonably mixing the traditional Chinese medicine components has the effects of improving sleep, energy and immunity, improving ulcer, enhancing detoxification capability and regulating blood sugar. Improving kidney function, reducing uric acid, and reducing nocturia.
Description
Technical Field
The invention relates to the technical field of health food, in particular to a multifunctional health tea composition.
Background
Tea is one of the favorite drinks, common tea comprises black tea, green tea, fruit tea, milk tea and the like, hot tea can effectively regulate body functions, and some tea can even detoxify and resist cancers.
With the continuous improvement of the living standard of people, people pay more and more attention to health preservation, the body of people is conditioned by methods of movement, psychological adjustment, diet, massage and the like, in diet, the importance of tea is self-evident, early tea can maintain skin, eliminate fatigue, delay aging and the like, afternoon tea can enhance memory, prevent sterol rise and the like, and comprehensively, health tea can effectively prevent apoplexy, improve vascular function, promote the discharge of body toxins, enhance immunity, beautify the face and nourish the skin and the like, so the health tea has great market power in the future, and the creation of the health tea is paid more and more attention.
At present, health-care tea on the market mostly concentrates on one efficacy, has single functionality, and some health-care tea have over-strong functionality and are not suitable for some people to use.
Disclosure of Invention
The invention provides a multifunctional health tea composition in order to overcome the problems that health tea in the prior art is single in function and not suitable for all people.
The purpose of the invention is realized by the following technical scheme:
the multifunctional health tea composition comprises the following components in parts by weight: 2-4 parts of cistanche, 1-3 parts of eurycoma longifolia, 1-3 parts of dendrobium officinale, 1-3 parts of American ginseng, 0.5-2 parts of radix ophiopogonis, 1-2 parts of morinda officinalis, 3-6 parts of poria cocos, 2-5 parts of medlar, 0.5-2 parts of liquorice, 2-4 parts of spina date seeds and 1-3 parts of dried orange peel.
Preferably, the composition comprises the following components in parts by weight: 2.5-3.2 parts of cistanche, 1.2-2.7 parts of Eurycoma longifolia, 1.3-2.4 parts of dendrobium officinale, 1.2-2.8 parts of American ginseng, 0.8-1.8 parts of radix ophiopogonis, 1.2-1.9 parts of morinda officinalis, 2.8-5.8 parts of poria cocos, 2.2-4.6 parts of medlar, 0.8-1.7 parts of liquorice, 2.6-3.8 parts of spina date seeds and 1.2-2.6 parts of dried orange peel.
Preferably, the composition comprises the following components in parts by weight: the traditional Chinese medicine composition comprises, by weight, 2.8 parts of cistanche, 1.8 parts of eurycoma longifolia, 2.1 parts of dendrobium officinale, 2.6 parts of American ginseng, 1.2 parts of radix ophiopogonis, 1.8 parts of morinda officinalis, 4.2 parts of poria cocos, 3.8 parts of medlar, 1.5 parts of liquorice, 3.1 parts of spina date seeds and 2.3 parts of dried orange peel.
Cistanche has a certain anti-aging effect. Cistanchis herba can obviously enhance the activity of mouse erythrocyte superoxide dismutase (SOD) and obviously reduce the content of myocardial lipofuscin in mouse. The average life span, half the death days and the maximum life span of the fruit flies can also be prolonged. Can regulate the decrease and increase of nucleic acid content in liver and spleen of animals with yang deficiency and yin deficiency; has the effects of activating adrenal gland and releasing corticoid. Improving immunity, remarkably increasing weight of spleen and thymus, remarkably enhancing phagocytic ability of abdominal macrophage, increasing hemolysin and PFC value, and improving lymphocyte transformation rate and delayed hypersensitivity index.
Eurycoma longifolia has the effects of resisting tumors and malaria, improving male sexual dysfunction and the like. In addition, the extract also has the effects of improving physical strength, relieving fatigue, sterilizing, resisting ulcer, reducing blood pressure, treating diabetes and the like, and is one of the precious applied botanical drugs in southeast Asia.
Dendrobium officinale has the effect of promoting the production of body fluid, and is mainly characterized by promoting glandular secretion and organ movement. Can reduce streptozotocin induced diabetes blood sugar value. Can promote the phagocytic function of macrophages of tumor-bearing animals, enhance the proliferation and differentiation of T lymphocytes and the activity of NK cells, and obviously improve the serum hemolysin value of the tumor-bearing animals.
The American ginseng has the functions of tonifying qi and yin, clearing heat and promoting fluid production. Can be used for treating deficiency of qi and yin, internal heat, cough, asthma, phlegm blood, asthenia, fever, vexation, fatigue, diabetes, xerostomia, and dry throat. The American ginseng has the functions of resisting fatigue, promoting urination and resisting anoxia, has better curative effects on hypertension, myocardial malnutrition, coronary heart disease, angina and the like, can relieve adverse reactions caused by radiotherapy and chemotherapy for cancer patients, and has the functions of improving the strain state of the body, relieving thymus gland and lymphatic tissue atrophy, nourishing and strengthening, nourishing blood and promoting the production of body fluid, calming the nerves and improving intelligence.
Compared with the prior art, the invention has the following technical effects:
the multifunctional health-preserving traditional Chinese medicine composition disclosed by the invention has the effects of improving sleep, improving energy, improving immunity, improving ulcer, enhancing detoxification capability and regulating blood sugar by reasonably mixing the traditional Chinese medicine components. Improving kidney function, reducing uric acid, and reducing nocturia.
Detailed Description
The technical solutions in the embodiments of the present invention will be clearly and completely described below with reference to the embodiments of the present invention, and it is obvious that the described embodiments are only a part of the embodiments of the present invention, and not all embodiments; all other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention. The starting materials used in the examples are all commercially available, unless otherwise specified.
Example 1
The multifunctional health-preserving important composition comprises the following components in parts by weight: 2.8 parts of cistanche, 1.8 parts of eurycoma longifolia, 2.1 parts of dendrobium officinale, 2.6 parts of American ginseng, 1.2 parts of radix ophiopogonis, 1.8 parts of morinda officinalis, 4.2 parts of poria cocos, 3.8 parts of medlar, 1.5 parts of liquorice, 3.1 parts of spina date seeds, 2.3 parts of pericarpium citri reticulatae and 0.9 part of snow chrysanthemum.
Example 2
The multifunctional health-preserving important composition comprises the following components in parts by weight: the traditional Chinese medicine composition comprises, by weight, 2 parts of cistanche, 3 parts of eurycoma longifolia, 1 part of dendrobium officinale, 3 parts of American ginseng, 2 parts of radix ophiopogonis, 2 parts of morinda officinalis, 3 parts of poria cocos, 2 parts of wolfberry, 0.5 part of liquorice, 4 parts of spina date seeds, 1 part of pericarpium citri reticulatae and 0.5 part of coreopsis tinctoria.
Example 3
The multifunctional health-preserving important composition comprises the following components in parts by weight: 4 parts of cistanche, 1 part of eurycoma longifolia, 3 parts of dendrobium officinale, 1 part of American ginseng, 0.5 part of radix ophiopogonis, 1 part of morinda officinalis, 6 parts of poria cocos, 5 parts of medlar, 2 parts of liquorice, 2 parts of spina date seed, 3 parts of pericarpium citri reticulatae and 1.5 parts of coreopsis tinctoria.
Comparative example 1
Compared with example 1, cistanche salsa is not added in the comparative example.
Comparative example 2
In contrast to example 1, no Eurycoma longifolia was added to this comparative example.
Comparative example 3
Compared with example 1, dendrobium officinale is not added in the comparative example.
Comparative example 4
In comparison with example 1, no American ginseng was added in this comparative example.
Examples of the experiments
The health tea compositions of each example and comparative example were brewed with hot water for use by different people. The health tea is continuously used by people for 1 month, and the investigation results of the conditions of different people are shown in the following table.
As can be seen from the above table, the health tea composition of the example is advantageous in maintaining energy, providing immunity to the human body to reduce canker sores, and reducing blood glucose and uric acid. Is beneficial to improving the renal function, obviously reduces the nocturia times and improves the sleep quality.
Although embodiments of the present invention have been shown and described, it will be appreciated by those skilled in the art that changes, modifications, substitutions and alterations can be made in these embodiments without departing from the principles and spirit of the invention, the scope of which is defined in the appended claims and their equivalents.
Claims (3)
1. The multifunctional health-preserving tea composition is characterized by comprising the following components in parts by weight: 2-4 parts of cistanche, 1-3 parts of eurycoma longifolia, 1-3 parts of dendrobium officinale, 1-3 parts of American ginseng, 0.5-2 parts of radix ophiopogonis, 1-2 parts of morinda officinalis, 3-6 parts of poria cocos, 2-5 parts of medlar, 0.5-2 parts of liquorice, 2-4 parts of spina date seeds, 1-3 parts of pericarpium citri reticulatae and 0.5-1.5 parts of snow chrysanthemum.
2. The multifunctional health tea composition according to claim 1, comprising the following components in parts by weight: 2.5 to 3.2 parts of cistanche, 1.2 to 2.7 parts of Eurycoma longifolia, 1.3 to 2.4 parts of dendrobium officinale, 1.2 to 2.8 parts of American ginseng, 0.8 to 1.8 parts of dwarf lilyturf tuber, 1.2 to 1.9 parts of morinda officinalis, 2.8 to 5.8 parts of tuckahoe, 2.2 to 4.6 parts of medlar, 0.8 to 1.7 parts of liquorice, 2.6 to 3.8 parts of spina date seed, 1.2 to 2.6 parts of dried orange peel and 0.8 to 1.2 parts of snow chrysanthemum.
3. The multifunctional health tea composition according to claim 1, comprising the following components in parts by weight: 2.8 parts of cistanche, 1.8 parts of eurycoma longifolia, 2.1 parts of dendrobium officinale, 2.6 parts of American ginseng, 1.2 parts of radix ophiopogonis, 1.8 parts of morinda officinalis, 4.2 parts of poria cocos, 3.8 parts of medlar, 1.5 parts of liquorice, 3.1 parts of spina date seeds, 2.3 parts of pericarpium citri reticulatae and 0.9 part of snow chrysanthemum.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211123122.0A CN115462429A (en) | 2022-09-15 | 2022-09-15 | Multifunctional health tea composition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211123122.0A CN115462429A (en) | 2022-09-15 | 2022-09-15 | Multifunctional health tea composition |
Publications (1)
Publication Number | Publication Date |
---|---|
CN115462429A true CN115462429A (en) | 2022-12-13 |
Family
ID=84332992
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202211123122.0A Pending CN115462429A (en) | 2022-09-15 | 2022-09-15 | Multifunctional health tea composition |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN115462429A (en) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105031204A (en) * | 2015-08-27 | 2015-11-11 | 上海天慈国际药业有限公司 | Tranquilizing health tea |
CN105475783A (en) * | 2015-11-30 | 2016-04-13 | 上海银源宝生物科技有限公司 | Drink for nourishing yin and invigorating yang and preparation method thereof |
CN106689569A (en) * | 2015-11-17 | 2017-05-24 | 济南健康人药品有限公司 | Eurycoma longifolia anti-fatigue health tea |
CN106819280A (en) * | 2016-12-27 | 2017-06-13 | 防城港市万景林业有限公司 | Health tea formula prepared by a kind of use Tongkat Ali, Momordica grosvenori |
CN106962549A (en) * | 2017-01-23 | 2017-07-21 | 丰泽阿里控股(香港)有限公司 | A kind of health preserving tea and preparation method thereof |
-
2022
- 2022-09-15 CN CN202211123122.0A patent/CN115462429A/en active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105031204A (en) * | 2015-08-27 | 2015-11-11 | 上海天慈国际药业有限公司 | Tranquilizing health tea |
CN106689569A (en) * | 2015-11-17 | 2017-05-24 | 济南健康人药品有限公司 | Eurycoma longifolia anti-fatigue health tea |
CN105475783A (en) * | 2015-11-30 | 2016-04-13 | 上海银源宝生物科技有限公司 | Drink for nourishing yin and invigorating yang and preparation method thereof |
CN106819280A (en) * | 2016-12-27 | 2017-06-13 | 防城港市万景林业有限公司 | Health tea formula prepared by a kind of use Tongkat Ali, Momordica grosvenori |
CN106962549A (en) * | 2017-01-23 | 2017-07-21 | 丰泽阿里控股(香港)有限公司 | A kind of health preserving tea and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103285231B (en) | Medicine composition for diabetes adjunctive therapy and preparation method thereof | |
CN104740308B (en) | A kind of hypoglycemic oral liquid of medical bio and preparation method thereof | |
CN104082672B (en) | A kind of health-preserving porridge with effect of lowering blood sugar and preparation method thereof | |
CN103169793B (en) | Medicine for treating hypertension, hyperlipoidemia and diabetes mellitus | |
CN111110792A (en) | Rhizoma polygonati and ginseng tea for controlling sugar, regulating lipid, reducing viscosity, preventing and treating diabetes and complications thereof | |
CN108887683A (en) | A kind of rice additive and its preparation process and the raw rice of medicine nourishment maintenance that medicine nourishment maintenance is raw | |
CN115462429A (en) | Multifunctional health tea composition | |
CN109393441A (en) | A kind of chick-pea Inonotus obliquus composition and preparation method thereof | |
CN106819219A (en) | A kind of compound tealeaves with blood-nourishing tonifying Qi effect | |
CN107019208A (en) | A kind of Chinese medicine ferment and preparation method thereof | |
CN106860814B (en) | Health food composition for improving female frequent micturition and urinary incontinence and preparation method and application thereof | |
CN110090282A (en) | For mitigating the Chinese medicine composition of gastrointestinal tract toxicity | |
CN104544064A (en) | Health food containing eaglewood leaves and having efficacy of reducing blood sugar and blood fat | |
CN107308266A (en) | A kind of female health preserving health composition and preparation method and application | |
CN106692760A (en) | Golden flower wine formula for preventing diabetes and preparation method thereof | |
CN102657277A (en) | All natural tri-hypo-effects (hypoglycemic, hypolipaemic and hypotensive effects) tea | |
CN105582412A (en) | Compound preparation for facilitating oncothlipsis postoperative healing and preparation method thereof | |
CN105343866A (en) | Traditional Chinese medicine tablets for treating cold rheum coughs and preparation method | |
CN101081078A (en) | Lotus seed ginkgo nut beverage | |
CN104984150A (en) | Preparing technology of health maintaining porridge with blood pressure reducing effect | |
KR20050001730A (en) | Composition for prevention and treatment of cancer | |
CN103349108A (en) | Warming-yang and tonifying-pleen healthy team cream and preparation method | |
CN107029108A (en) | A kind of anti-aging takes care of health the medicine food composition and its preparation of macrobiosis | |
CN107485680A (en) | A kind of Chinese medicine for treating breast cancer | |
CN106344655A (en) | Traditional Chinese medicinal composition with blood glucose reducing effect and manufacturing method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20221213 |
|
WD01 | Invention patent application deemed withdrawn after publication |